Articles tagged with Personalized Medicine
Researchers developed a breakthrough technology using Mirvie's RNA platform to identify unique molecular signals in unborn babies. This innovation enables prediction of severe fetal growth restriction, a leading cause of stillbirth.
A national survey of 1,008 Americans found that nearly two-thirds use a device to monitor their heart health, but only one in four shares the data with their doctor. This lack of sharing can lead to delayed diagnosis and treatment, emphasizing the importance of proactive communication between patients and healthcare providers.
Researchers developed a system to monitor tumor-informed circulating tumor DNA (ctDNA) after comprehensive genomic profiling (CGP), enabling accurate prediction of patient outcomes. The study showed that this approach can be effectively used in conjunction with CGP data to predict cancer relapse and treatment response, improving person...
A team of researchers developed a web-based system called 'DeepMerkel' to predict Merkel cell carcinoma treatment specific outcomes based on personal and tumour specific features. The system was able to accurately identify high-risk patients at an earlier stage, enabling informed clinical decision making and improved patient choice.
The University of Plymouth and International Osteopathic Education have formed a partnership to provide a comprehensive Master of Osteopathic Medicine program. The five-year program offers flexible study, clinical teaching in France and international partner clinics, and prepares students for an interdisciplinary practice.
Researchers analyzed individual cells from two craniopharyngioma subtypes to identify specific cell types, their features, and interactions. The study found distinct cell types linked to tumor development and immune response in both adamantinomatous and papillary craniopharyngiomas.
Researchers have developed a new generation of cell-penetrating antibodies that can target cancer cells and deliver therapeutic molecules directly into tumor cells. The 3E10 antibody shows great promise for treating cancers with defective DNA repair pathways.
A groundbreaking study has established the world's largest and most geographically comprehensive international norms for handgrip strength, covering 2.4 million adults from 69 countries. The new norms enable global peer-comparison, health screening, and surveillance across the adult lifespan, helping clinicians identify people at risk ...
A team of UNC-Chapel Hill researchers will develop an oncology health learning system using AI-ready data to generate real-time identification of new cancer cases and support personalized treatments. The project aims to improve cancer diagnosis, care equity, and quality by creating accessible tools for health providers.
A 10-minute brain scan can predict the effectiveness of a risky spinal surgery to alleviate intractable pain. The study found that patients who responded better to spinal cord stimulation therapy had weaker connections between certain brain networks.
A new study reveals that patients with Parkinson's disease who exhibit rest tremor have more dopamine preserved in the caudate nucleus, a part of the brain important for movement planning and cognition. This challenges traditional understanding of how dopamine loss relates to PD symptoms.
A new study introduces the PWAS Hub, a powerful tool that explores gene-disease connections across 99 common diseases. The platform identifies genes linked to specific conditions and provides valuable genetic insights for clinicians and researchers.
A new study by uOttawa highlights the importance of providing culturally and linguistically concordant care to avoid inappropriate prescribing of antipsychotics. Francophone and Allophone residents are more likely to experience inappropriateness compared to English-language patients.
The C-Path initiative aims to generate drug development solutions that reflect each person's unique experience, leveraging diverse data and innovative technologies like AI and digital health. GEM-PD seeks to address unmet need in Parkinson's disease therapies by focusing on sex and gender differences.
The new CAMP 2.0 tool provides personalized medicine for managing allergic contact dermatitis by generating safe lists based on individual patch testing results. It offers thousands of product options and interactive tools to help patients find safe products, track their quality of life, and understand their allergens.
The CRISPR tool was successfully used to correct a genetic defect in cells affected by chronic granulomatous disease. However, the repair process also introduced new genetic defects, highlighting the need for caution when using CRISPR technology in clinical settings.
Researchers develop transcranial ultrasound stimulation (TUS) as a non-invasive therapy for brain-related issues, with potential for personalized treatments. A 'search and rescue tool' for the brain, TUS enables precise targeting of specific areas before treatment.
Scientists have developed a new method using artificial intelligence to design thousands of DNA switches that can activate or repress genes in specific cell types. This approach could revolutionize gene therapy and biotechnology by allowing precise control over gene expression in the body.
Researchers have made a breakthrough in understanding the rare autoimmune disease anti-NMDAR encephalitis, which can cause psychosis, hallucinations, and blackouts. The study found that different antibodies bind to NMDA receptors in unique ways, suggesting personalized medicine may be key to treating the condition.
A peer-reviewed study published in NEJM Catalyst found Waymark's early intervention model significantly improved clinical outcomes for patients receiving Medicaid, reducing hospital and ED visits by 22.9%. The study also showed improved patient goal completion and care quality.
A study from Lehigh University and Seattle University found that making patients aware of biases in human healthcare decisions increases receptiveness to AI recommendations. By highlighting the limitations of human judgment, healthcare providers can create a more balanced relationship between patients and emerging technologies.
A longitudinal study tracked one person's brain activity for five months, revealing how daily life affects brain function. The research found that physical activity positively influences brain regions, while subtle shifts in mood and heart rate leave lasting imprints for up to fifteen days.
A new technique called Clonal competition assays helps understand the evolutionary advantages of multiple myeloma cells over available treatments. It allows researchers to see how each population of cells in the same myeloma reacts to treatments, getting closer to understanding heterogeneity and resistance.
Researchers have developed a new treatment for deep diabetic foot ulcers, using intact fish skin grafts to promote healing. The study found that this innovative approach showed promising results in improving wound closure and reducing infection rates.
A recent study published in iScience found that the length of time cells spend engaged in the repair process is also key to regulating regeneration in African killifish. The researchers discovered that skin cells launch a genetic program that primes the whole animal to prepare for a repair response, guiding repair cells to get to work.
Researchers at ETH Zurich have found an antidepressant, vortioxetine, effective against glioblastomas, a particularly aggressive brain tumor with no cure. The drug's ability to cross the blood-brain barrier and trigger a signalling cascade makes it promising for treating this deadly tumour.
A phase 1b/2 clinical trial found a combination of immunotherapy and FGFR inhibitor to be safe and tolerable in patients with locally advanced or metastatic bladder cancer. The treatment showed increased response rates, including 54% for patients with high FGFR mRNA expression.
A study by IRB Barcelona researchers has identified five independent factors that determine patients' response and survival after receiving checkpoint inhibitors, a type of immunotherapy. These findings provide a framework for current and future biomarkers of immunotherapy response and could lead to more accurate patient classification.
ISTA's Lisa Bugnet, Alicia Michael, and Marco Mondelli have been awarded ERC Starting Grants to develop new methods for extracting information from data, studying gene regulation, and understanding time-keeping in cells. Their projects aim to simplify data analysis, accelerate personalized medicine, and uncover the secrets of biologica...
Researchers at CNIC discover clonal hematopoiesis as a new cause of atherosclerosis, while identifying the ancient medication colchicine as a potential treatment. Clonal hematopoiesis is linked to an increased risk of cardiovascular disease, with no influence on the progression of mutated blood cells.
Researchers have developed a cost-effective and easily reproducible point-of-care testing device that can accurately measure cortisol levels in the blood. The device uses iridium oxide nanoparticles to improve stability, sensitivity, and selectivity, allowing for commercial use.
A multi-university research team led by University of Virginia engineering professor Gustavo K. Rohde has developed a system that can accurately spot genetic markers of autism in brain images. The system uses generative computer modeling technique called transport-based morphometry, which reveals brain structure patterns that predict v...
Holotomography offers a promising approach to biomedical research, providing high-resolution images of live cells and tissues at the organelle level. The KAIST research team has developed core technologies and demonstrated its applications in various fields, including regenerative medicine and cancer research.
A new study published in Nature Medicine shows that precision therapy can improve survival for men with metastatic castration-resistant prostate cancer. The treatment, which involves analyzing the genetic profile of the tumor, has been shown to be more effective than chemotherapy in patients whose tumors have specific mutations.
Researchers at the Centre for Genomic Regulation have discovered a treatment that speeds up the production of high-quality pluripotent stem cells in mice. The finding uses interferon gamma to accelerate cellular reprogramming, paving the way for improved disease modeling and personalized treatments.
Researchers have identified distinct molecular and immune subtypes across individuals with Down syndrome, providing new insights for personalized medicine approaches. The study's findings could lead to tailored diagnostics and therapeutic approaches, addressing the unique manifestations of co-occurring conditions.
Liheng Cai, a UVA engineering professor, has received a $1.9 million NIH grant to create advanced biomaterials that can be used to repair living tissues and build organ structures. His lab aims to develop polymers that mimic human biology and integrate healthy cells into the human body.
The PD GENEration study has found that 13% of participants have a genetic form of Parkinson's disease, significantly higher than previous estimates. The study, which reached its goal of 15,000 participants ahead of schedule, provides insights into the genetics of the disease and its potential for precision medicine.
Researchers measured thousands of blood proteins and found signatures that can predict the onset of 67 diseases, including multiple myeloma and cardiovascular risks. The protein prediction models outperformed standard clinical information in predicting disease risk.
Developed by University of Tsukuba researchers, the wearable patch accurately measures insensible perspiration, allowing for real-time hydration monitoring. The patch also detects variations in pH levels and chemical components, making it a promising tool for dehydration management, stress monitoring, and disease detection.
Researchers at Osaka University have developed molecules that can correct improper splicing of a vital tumor suppressor gene in neuroendocrine cancers. The study demonstrates that these splice-switching oligonucleotides can significantly reduce viable cancer cells and tumor size in mice, suggesting a novel therapeutic approach for intr...
A new liquid biopsy method analyzes gene fragments in the bloodstream to detect and track cancer, enabling oncologists to tailor treatment approaches to individual patients. This non-invasive test can help monitor treatment success, detect cancer recurrence, and improve patient quality of life.
A first-of-its-kind study compared preventative therapy efficacy between two groups: gene therapy alone and in combination with risdiplam or nusinersen. Dual therapy showed promise in independent sitting outcomes, but not in walking age or muscle disease progression prevention.
A Kobe University study finds that a new treatment for neuromyelitis optica spectrum disorder shifts the balance of immune cells, increasing anti-inflammatory signals. The discovery may enable clinicians to determine treatment effectiveness and move towards personalized medicine for autoimmune diseases.
Telo-seq reveals dynamic mechanisms of telomeres in aging and cancer, providing new insights into their role in health and disease. The breakthrough method determines telomere length and sequence on individual chromosomes.
Hormonally.org provides free-to-access, evidence-based resources on women's hormonal health, empowering women to seek care, treatment, and support. The nonprofit addresses stigmas and misinformation surrounding women's hormonal issues, fostering a supportive online community for connection and shared decision-making.
This review bridges traditional wisdom and modern science to examine the safety, efficacy, and bioactivity of herbal medicines. It highlights successful case studies where herbal remedies enhance patient outcomes when used alongside conventional treatments.
The new law recognizes personalized medicine as a fundamental patient right, emphasizing individualized treatment and care. It sets a precedent for future health care innovations worldwide, integrating genomics, proteomics, and AI technologies.
The Ottawa Hospital is receiving a $59 million grant to boost Canada's capacity for life-saving biotherapeutics, including vaccines, gene therapies, and cell therapies. The funding will support the construction and operation of a world-class biomanufacturing facility at its new campus.
Hangbo Zhao's new research enables the development of soft, flexible microneedle electrodes that can sense into tissues and gain accurate results. The technology is enabled by a novel manufacturing process that combines laser micromachining, microfabrication, and transfer printing.
A new set of clinical practice standards and recommendations offers tailored and effective care for individuals with advanced and metastatic cancer. The initiative, backed by MASCC and ASCO, provides a critical resource to healthcare stakeholders.
A survey of healthcare providers in the Middle East reveals a good understanding of halal pharmaceuticals, but gaps in knowledge, particularly about ingredients and aligning with Islamic principles. Personalized education and culturally sensitive care can address patient concerns and improve healthcare outcomes for all patients.
Researchers at the University of Missouri have developed a soft, self-charging material that can track vital signs like blood pressure and heart activity wirelessly. This innovation has significant implications for early disease detection and timely interventions in chronic conditions.
The position paper identifies eight key areas for digital neuroscience research, including near-term, middle-term, and long-term goals. It also discusses the potential of 'digital twin' approaches, ultra-high-resolution digital atlases, and neuro-derived AI and computing innovations.
A study published in The Lancet Gastroenterology & Hepatology found that dietary adjustments, such as a low FODMAP diet and low-carbohydrate diets, resulted in significantly reduced IBS symptoms for over seven out of ten patients. In contrast, medication-based treatment showed fewer symptom improvements.
A groundbreaking treatment approach that combines genetic testing with individualized drug testing on tumor samples has shown promising results in treating relapsed pediatric cancer patients. The study achieved an impressive 83% improvement rate, including Logan Jenner's successful treatment after his leukemia relapse.
A new study found that access to genomic testing for cancer is limited by factors such as test availability, patient information, and insurance coverage in both Japan and Switzerland. Despite universal insurance coverage, barriers persist due to differences in hospital accessibility, language barriers, and varying levels of reimbursement.
Researchers have identified three distinct immunological endophenotypes of multiple sclerosis, defined by specific blood immune signatures. These findings could lead to more effective and tailored treatment strategies for patients with the disease.
A team of Arizona State University scientists has developed an AI-based learning tool called HLA Inception that can classify individual proteins and predict immune responses. The tool uses machine learning to analyze electrostatic signatures on MHC-1 proteins, enabling faster predictions than traditional methods.
A retrospective cohort study found that PERT significantly reduced the incidence of acute pancreatitis episodes among children with recurrent or chronic pancreatitis. The study also identified genetic markers, such as SPINK1 mutation, that influence treatment outcomes and suggest a tailored approach to patient care.